Safety and Efficacy of 166Ho Radioembolization in Hepatocellular Carcinoma: The HEPAR Primary Study.
Reinders MTM, van Erpecum KJ, Smits MLJ, Braat AJAT, Bruijne J, Bruijnen R, Sprengers D, Man RA, Vegt E, IJzermans JNM, Moelker A, Lam MGEH.
Reinders MTM, et al. Among authors: vegt e.
J Nucl Med. 2022 Dec;63(12):1891-1898. doi: 10.2967/jnumed.122.263823. Epub 2022 May 19.
J Nucl Med. 2022.
PMID: 35589409
Free PMC article.
Clinical Trial.